Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2626
Northern Technologies International Corp
NTIC
$73M
| $777K | ﹤0.01% |
104,877
+21,300
| +25% | +$163K |
2014 Q4
42 quarters
|
|
2627
First Mid Bancshares
FMBH
$1.29B
| $776K | ﹤0.01% |
20,700
-10,900
| -34% | -$381K |
2023 Q3
7 quarters
|
|
2628
DELISTED
LivePerson
LPSN
| $771K | ﹤0.01% |
50,900
+987
| +2% | +$11.7K |
2023 Q2
8 quarters
|
|
2629
Heritage Global
HGBL
$43.3M
| $769K | ﹤0.01% |
346,506
+97,715
| +39% | +$205K |
2021 Q1
17 quarters
|
|
2630
Reading International Class A
RDI
$43.3M
| $768K | ﹤0.01% |
573,290
-11,800
| -2% | -$15.7K |
2013 Q2
48 quarters
|
|
2631
Mercer International
MERC
$16M
| $765K | ﹤0.01% |
218,611
-43,100
| -16% | -$178K |
2014 Q3
43 quarters
|
|
2632
Pulmatrix
PULM
$5.33M
| $765K | ﹤0.01% |
110,820
+1,900
| +2% | +$13.1K |
2019 Q4
22 quarters
|
|
2633
Montauk Renewables
MNTK
$360M
| $764K | ﹤0.01% |
344,213
+59,713
| +21% | +$126K |
2022 Q2
12 quarters
|
|
2634
Plumas Bancorp
PLBC
$424M
| $760K | ﹤0.01% |
17,100
-300
| -2% | -$12.9K |
2022 Q4
10 quarters
|
|
2635
Axcelis
ACLS
$4.16B
| $760K | ﹤0.01% |
10,899
-78,600
| -88% | -$4.48M |
2024 Q3
3 quarters
|
|
2636
Vor Biopharma
VOR
$1.18B
| $758K | ﹤0.01% |
23,406
-11,666
| -33% | -$103K |
2022 Q2
12 quarters
|
|
2637
Orion Energy Systems
OESX
$106M
| $757K | ﹤0.01% |
126,164
+419
| +0.3% | +$2.84K |
2013 Q2
48 quarters
|
|
2638
Kenon Holdings
KEN
$3.12B
| $752K | ﹤0.01% |
18,100
-100
| -0.5% | -$3.35K |
2022 Q1
13 quarters
|
|
2639
iShares MSCI Taiwan ETF
EWT
$12.5B
| $752K | ﹤0.01% |
+13,100
| New | +$670K |
2025 Q2
0 quarters
|
|
2640
Sabre
SABR
$767M
| $748K | ﹤0.01% |
+236,749
| New | +$607K |
2025 Q2
0 quarters
|
|
2641
Farmers National Banc Corp
FMNB
$887M
| $746K | ﹤0.01% |
54,128
-10,100
| -16% | -$132K |
2014 Q4
42 quarters
|
|
2642
Avantis US Equity ETF
AVUS
$14.7B
| $746K | ﹤0.01% |
7,400
-8,500
| -53% | -$796K |
2022 Q2
12 quarters
|
|
2643
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.18B
| $746K | ﹤0.01% |
16,473
+2,435
| +17% | +$105K |
2023 Q4
6 quarters
|
|
2644
iShares Core S&P 500 ETF
IVV
$899B
| $745K | ﹤0.01% |
+1,200
| New | +$689K |
2025 Q2
0 quarters
|
|
|
OCFT
2645
DELISTED
OneConnect Financial Technology
OCFT
| $742K | ﹤0.01% |
103,060
+24,500
| +31% | +$163K |
2021 Q1
17 quarters
|
|
2646
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.65B
| $741K | ﹤0.01% |
17,700
-97,200
| -85% | -$4.01M |
2025 Q1
1 quarter
|
|
2647
Legacy Education Inc
LGCY
$131M
| $740K | ﹤0.01% |
66,200
-6,640
| -9% | -$54.4K |
2024 Q4
2 quarters
|
|
2648
DELISTED
Y-mAbs Therapeutics
YMAB
| $740K | ﹤0.01% |
164,100
-92,606
| -36% | -$416K |
2021 Q4
14 quarters
|
|
2649
A2Z Smart Technologies
AZ
$254M
| $739K | ﹤0.01% |
+69,900
| New | +$598K |
2025 Q2
0 quarters
|
|
2650
DELISTED
Forge Global Holdings
FRGE
| $738K | ﹤0.01% |
38,779
+19,379
| +100% | +$266K |
2023 Q4
6 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.